nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—ABCB1—colon cancer	0.74	1	CbGaD
Reboxetine—ABCB1—Irinotecan—colon cancer	0.0233	0.284	CbGbCtD
Reboxetine—ABCB1—Vincristine—colon cancer	0.0204	0.248	CbGbCtD
Reboxetine—CYP3A4—Irinotecan—colon cancer	0.014	0.17	CbGbCtD
Reboxetine—ABCB1—Methotrexate—colon cancer	0.0123	0.15	CbGbCtD
Reboxetine—CYP3A4—Vincristine—colon cancer	0.0122	0.148	CbGbCtD
Reboxetine—Connective tissue disorder—Irinotecan—colon cancer	0.000712	0.00399	CcSEcCtD
Reboxetine—Hyponatraemia—Capecitabine—colon cancer	0.000704	0.00395	CcSEcCtD
Reboxetine—Diplopia—Capecitabine—colon cancer	0.000701	0.00393	CcSEcCtD
Reboxetine—Visual impairment—Irinotecan—colon cancer	0.000698	0.00392	CcSEcCtD
Reboxetine—Rhinitis—Fluorouracil—colon cancer	0.000695	0.0039	CcSEcCtD
Reboxetine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.000695	0.0039	CcSEcCtD
Reboxetine—Cardiac disorder—Vincristine—colon cancer	0.00069	0.00387	CcSEcCtD
Reboxetine—Pharyngitis—Fluorouracil—colon cancer	0.000688	0.00386	CcSEcCtD
Reboxetine—Face oedema—Capecitabine—colon cancer	0.000676	0.0038	CcSEcCtD
Reboxetine—Angiopathy—Vincristine—colon cancer	0.000675	0.00379	CcSEcCtD
Reboxetine—Cardiac disorder—Irinotecan—colon cancer	0.000672	0.00377	CcSEcCtD
Reboxetine—Mediastinal disorder—Vincristine—colon cancer	0.00067	0.00376	CcSEcCtD
Reboxetine—Irritability—Capecitabine—colon cancer	0.000669	0.00375	CcSEcCtD
Reboxetine—Urinary retention—Capecitabine—colon cancer	0.000666	0.00374	CcSEcCtD
Reboxetine—Angiopathy—Irinotecan—colon cancer	0.000657	0.00369	CcSEcCtD
Reboxetine—Blood creatinine increased—Capecitabine—colon cancer	0.000656	0.00368	CcSEcCtD
Reboxetine—Immune system disorder—Irinotecan—colon cancer	0.000654	0.00367	CcSEcCtD
Reboxetine—Mediastinal disorder—Irinotecan—colon cancer	0.000653	0.00366	CcSEcCtD
Reboxetine—Dehydration—Capecitabine—colon cancer	0.000652	0.00366	CcSEcCtD
Reboxetine—Mental disorder—Vincristine—colon cancer	0.000652	0.00366	CcSEcCtD
Reboxetine—Chills—Irinotecan—colon cancer	0.00065	0.00365	CcSEcCtD
Reboxetine—Liver function test abnormal—Capecitabine—colon cancer	0.000647	0.00363	CcSEcCtD
Reboxetine—Orthostatic hypotension—Capecitabine—colon cancer	0.00064	0.00359	CcSEcCtD
Reboxetine—Breast disorder—Capecitabine—colon cancer	0.000633	0.00355	CcSEcCtD
Reboxetine—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000618	0.00347	CcSEcCtD
Reboxetine—Muscular weakness—Capecitabine—colon cancer	0.000618	0.00347	CcSEcCtD
Reboxetine—Influenza—Capecitabine—colon cancer	0.000606	0.0034	CcSEcCtD
Reboxetine—Anaemia—Vincristine—colon cancer	0.000598	0.00336	CcSEcCtD
Reboxetine—Agitation—Vincristine—colon cancer	0.000595	0.00334	CcSEcCtD
Reboxetine—Ill-defined disorder—Irinotecan—colon cancer	0.000585	0.00328	CcSEcCtD
Reboxetine—Anaemia—Irinotecan—colon cancer	0.000583	0.00327	CcSEcCtD
Reboxetine—Bronchitis—Capecitabine—colon cancer	0.000582	0.00327	CcSEcCtD
Reboxetine—Vertigo—Vincristine—colon cancer	0.000582	0.00326	CcSEcCtD
Reboxetine—Leukopenia—Vincristine—colon cancer	0.000579	0.00325	CcSEcCtD
Reboxetine—Malaise—Irinotecan—colon cancer	0.000569	0.00319	CcSEcCtD
Reboxetine—Vertigo—Irinotecan—colon cancer	0.000566	0.00318	CcSEcCtD
Reboxetine—Dysuria—Capecitabine—colon cancer	0.000566	0.00318	CcSEcCtD
Reboxetine—Syncope—Irinotecan—colon cancer	0.000565	0.00317	CcSEcCtD
Reboxetine—Leukopenia—Irinotecan—colon cancer	0.000564	0.00317	CcSEcCtD
Reboxetine—Hypertension—Vincristine—colon cancer	0.000559	0.00314	CcSEcCtD
Reboxetine—Anaemia—Fluorouracil—colon cancer	0.000558	0.00313	CcSEcCtD
Reboxetine—Loss of consciousness—Irinotecan—colon cancer	0.000554	0.00311	CcSEcCtD
Reboxetine—Weight decreased—Capecitabine—colon cancer	0.000548	0.00308	CcSEcCtD
Reboxetine—Hyperglycaemia—Capecitabine—colon cancer	0.000546	0.00307	CcSEcCtD
Reboxetine—Hypertension—Irinotecan—colon cancer	0.000544	0.00306	CcSEcCtD
Reboxetine—Leukopenia—Fluorouracil—colon cancer	0.000541	0.00303	CcSEcCtD
Reboxetine—Infestation NOS—Capecitabine—colon cancer	0.00054	0.00303	CcSEcCtD
Reboxetine—Infestation—Capecitabine—colon cancer	0.00054	0.00303	CcSEcCtD
Reboxetine—Discomfort—Irinotecan—colon cancer	0.00053	0.00298	CcSEcCtD
Reboxetine—Infection—Vincristine—colon cancer	0.000525	0.00295	CcSEcCtD
Reboxetine—Urinary tract infection—Capecitabine—colon cancer	0.000525	0.00295	CcSEcCtD
Reboxetine—Conjunctivitis—Capecitabine—colon cancer	0.000525	0.00295	CcSEcCtD
Reboxetine—Confusional state—Irinotecan—colon cancer	0.000519	0.00291	CcSEcCtD
Reboxetine—Nervous system disorder—Vincristine—colon cancer	0.000518	0.00291	CcSEcCtD
Reboxetine—Chest pain—Fluorouracil—colon cancer	0.000514	0.00289	CcSEcCtD
Reboxetine—Infection—Irinotecan—colon cancer	0.000511	0.00287	CcSEcCtD
Reboxetine—Hyperhidrosis—Vincristine—colon cancer	0.000511	0.00287	CcSEcCtD
Reboxetine—Epistaxis—Capecitabine—colon cancer	0.000509	0.00286	CcSEcCtD
Reboxetine—Discomfort—Fluorouracil—colon cancer	0.000508	0.00285	CcSEcCtD
Reboxetine—Shock—Irinotecan—colon cancer	0.000506	0.00284	CcSEcCtD
Reboxetine—Nervous system disorder—Irinotecan—colon cancer	0.000505	0.00283	CcSEcCtD
Reboxetine—Anorexia—Vincristine—colon cancer	0.000504	0.00283	CcSEcCtD
Reboxetine—Irritability—Methotrexate—colon cancer	0.000498	0.00279	CcSEcCtD
Reboxetine—Hyperhidrosis—Irinotecan—colon cancer	0.000497	0.00279	CcSEcCtD
Reboxetine—Confusional state—Fluorouracil—colon cancer	0.000497	0.00279	CcSEcCtD
Reboxetine—Hypotension—Vincristine—colon cancer	0.000494	0.00277	CcSEcCtD
Reboxetine—Bradycardia—Capecitabine—colon cancer	0.000493	0.00277	CcSEcCtD
Reboxetine—Anorexia—Irinotecan—colon cancer	0.00049	0.00275	CcSEcCtD
Reboxetine—Infection—Fluorouracil—colon cancer	0.00049	0.00275	CcSEcCtD
Reboxetine—Rhinitis—Capecitabine—colon cancer	0.000486	0.00273	CcSEcCtD
Reboxetine—Nervous system disorder—Fluorouracil—colon cancer	0.000483	0.00271	CcSEcCtD
Reboxetine—Liver function test abnormal—Methotrexate—colon cancer	0.000482	0.0027	CcSEcCtD
Reboxetine—Pharyngitis—Capecitabine—colon cancer	0.000481	0.0027	CcSEcCtD
Reboxetine—Tachycardia—Fluorouracil—colon cancer	0.000481	0.0027	CcSEcCtD
Reboxetine—Hypotension—Irinotecan—colon cancer	0.000481	0.0027	CcSEcCtD
Reboxetine—Urinary tract disorder—Capecitabine—colon cancer	0.000479	0.00269	CcSEcCtD
Reboxetine—Insomnia—Vincristine—colon cancer	0.000478	0.00268	CcSEcCtD
Reboxetine—Connective tissue disorder—Capecitabine—colon cancer	0.000476	0.00267	CcSEcCtD
Reboxetine—Urethral disorder—Capecitabine—colon cancer	0.000475	0.00267	CcSEcCtD
Reboxetine—Paraesthesia—Vincristine—colon cancer	0.000474	0.00266	CcSEcCtD
Reboxetine—Breast disorder—Methotrexate—colon cancer	0.000471	0.00265	CcSEcCtD
Reboxetine—Anorexia—Fluorouracil—colon cancer	0.00047	0.00264	CcSEcCtD
Reboxetine—Visual impairment—Capecitabine—colon cancer	0.000467	0.00262	CcSEcCtD
Reboxetine—Insomnia—Irinotecan—colon cancer	0.000465	0.00261	CcSEcCtD
Reboxetine—Paraesthesia—Irinotecan—colon cancer	0.000462	0.00259	CcSEcCtD
Reboxetine—Hypotension—Fluorouracil—colon cancer	0.000461	0.00258	CcSEcCtD
Reboxetine—Decreased appetite—Vincristine—colon cancer	0.000459	0.00258	CcSEcCtD
Reboxetine—Dyspnoea—Irinotecan—colon cancer	0.000459	0.00257	CcSEcCtD
Reboxetine—Somnolence—Irinotecan—colon cancer	0.000457	0.00257	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Vincristine—colon cancer	0.000456	0.00256	CcSEcCtD
Reboxetine—Eye disorder—Capecitabine—colon cancer	0.000453	0.00254	CcSEcCtD
Reboxetine—Dyspepsia—Irinotecan—colon cancer	0.000453	0.00254	CcSEcCtD
Reboxetine—Tinnitus—Capecitabine—colon cancer	0.000452	0.00254	CcSEcCtD
Reboxetine—Constipation—Vincristine—colon cancer	0.000452	0.00254	CcSEcCtD
Reboxetine—Cardiac disorder—Capecitabine—colon cancer	0.00045	0.00252	CcSEcCtD
Reboxetine—Decreased appetite—Irinotecan—colon cancer	0.000447	0.00251	CcSEcCtD
Reboxetine—Insomnia—Fluorouracil—colon cancer	0.000446	0.0025	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000444	0.00249	CcSEcCtD
Reboxetine—Paraesthesia—Fluorouracil—colon cancer	0.000443	0.00248	CcSEcCtD
Reboxetine—Constipation—Irinotecan—colon cancer	0.00044	0.00247	CcSEcCtD
Reboxetine—Angiopathy—Capecitabine—colon cancer	0.00044	0.00247	CcSEcCtD
Reboxetine—Dyspnoea—Fluorouracil—colon cancer	0.000439	0.00247	CcSEcCtD
Reboxetine—Somnolence—Fluorouracil—colon cancer	0.000438	0.00246	CcSEcCtD
Reboxetine—Immune system disorder—Capecitabine—colon cancer	0.000438	0.00246	CcSEcCtD
Reboxetine—Mediastinal disorder—Capecitabine—colon cancer	0.000437	0.00245	CcSEcCtD
Reboxetine—Chills—Capecitabine—colon cancer	0.000435	0.00244	CcSEcCtD
Reboxetine—Dyspepsia—Fluorouracil—colon cancer	0.000434	0.00243	CcSEcCtD
Reboxetine—Gastrointestinal pain—Vincristine—colon cancer	0.000432	0.00242	CcSEcCtD
Reboxetine—Decreased appetite—Fluorouracil—colon cancer	0.000428	0.0024	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000425	0.00239	CcSEcCtD
Reboxetine—Mental disorder—Capecitabine—colon cancer	0.000425	0.00238	CcSEcCtD
Reboxetine—Feeling abnormal—Irinotecan—colon cancer	0.000424	0.00238	CcSEcCtD
Reboxetine—Malnutrition—Capecitabine—colon cancer	0.000422	0.00237	CcSEcCtD
Reboxetine—Dysuria—Methotrexate—colon cancer	0.000422	0.00237	CcSEcCtD
Reboxetine—Gastrointestinal pain—Irinotecan—colon cancer	0.000421	0.00236	CcSEcCtD
Reboxetine—Body temperature increased—Vincristine—colon cancer	0.000418	0.00234	CcSEcCtD
Reboxetine—Abdominal pain—Vincristine—colon cancer	0.000418	0.00234	CcSEcCtD
Reboxetine—Erectile dysfunction—Methotrexate—colon cancer	0.000415	0.00233	CcSEcCtD
Reboxetine—Dysgeusia—Capecitabine—colon cancer	0.000413	0.00232	CcSEcCtD
Reboxetine—Abdominal pain—Irinotecan—colon cancer	0.000407	0.00228	CcSEcCtD
Reboxetine—Body temperature increased—Irinotecan—colon cancer	0.000407	0.00228	CcSEcCtD
Reboxetine—Feeling abnormal—Fluorouracil—colon cancer	0.000406	0.00228	CcSEcCtD
Reboxetine—Infestation NOS—Methotrexate—colon cancer	0.000402	0.00226	CcSEcCtD
Reboxetine—Infestation—Methotrexate—colon cancer	0.000402	0.00226	CcSEcCtD
Reboxetine—Tremor—Capecitabine—colon cancer	0.000395	0.00222	CcSEcCtD
Reboxetine—Ill-defined disorder—Capecitabine—colon cancer	0.000392	0.0022	CcSEcCtD
Reboxetine—Urticaria—Fluorouracil—colon cancer	0.000392	0.0022	CcSEcCtD
Reboxetine—Conjunctivitis—Methotrexate—colon cancer	0.000391	0.00219	CcSEcCtD
Reboxetine—Anaemia—Capecitabine—colon cancer	0.00039	0.00219	CcSEcCtD
Reboxetine—Body temperature increased—Fluorouracil—colon cancer	0.00039	0.00219	CcSEcCtD
Reboxetine—Hypersensitivity—Vincristine—colon cancer	0.000389	0.00218	CcSEcCtD
Reboxetine—Sweating—Methotrexate—colon cancer	0.000385	0.00216	CcSEcCtD
Reboxetine—Malaise—Capecitabine—colon cancer	0.000381	0.00214	CcSEcCtD
Reboxetine—Epistaxis—Methotrexate—colon cancer	0.000379	0.00213	CcSEcCtD
Reboxetine—Vertigo—Capecitabine—colon cancer	0.000379	0.00213	CcSEcCtD
Reboxetine—Hypersensitivity—Irinotecan—colon cancer	0.000379	0.00213	CcSEcCtD
Reboxetine—Asthenia—Vincristine—colon cancer	0.000379	0.00213	CcSEcCtD
Reboxetine—Syncope—Capecitabine—colon cancer	0.000378	0.00212	CcSEcCtD
Reboxetine—Leukopenia—Capecitabine—colon cancer	0.000378	0.00212	CcSEcCtD
Reboxetine—Palpitations—Capecitabine—colon cancer	0.000373	0.00209	CcSEcCtD
Reboxetine—Loss of consciousness—Capecitabine—colon cancer	0.000371	0.00208	CcSEcCtD
Reboxetine—Asthenia—Irinotecan—colon cancer	0.000369	0.00207	CcSEcCtD
Reboxetine—Hypertension—Capecitabine—colon cancer	0.000364	0.00204	CcSEcCtD
Reboxetine—Hypersensitivity—Fluorouracil—colon cancer	0.000363	0.00204	CcSEcCtD
Reboxetine—Diarrhoea—Vincristine—colon cancer	0.000362	0.00203	CcSEcCtD
Reboxetine—Chest pain—Capecitabine—colon cancer	0.000359	0.00202	CcSEcCtD
Reboxetine—Pharyngitis—Methotrexate—colon cancer	0.000358	0.00201	CcSEcCtD
Reboxetine—Anxiety—Capecitabine—colon cancer	0.000358	0.00201	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000357	0.002	CcSEcCtD
Reboxetine—Urinary tract disorder—Methotrexate—colon cancer	0.000356	0.002	CcSEcCtD
Reboxetine—Discomfort—Capecitabine—colon cancer	0.000355	0.00199	CcSEcCtD
Reboxetine—Urethral disorder—Methotrexate—colon cancer	0.000354	0.00199	CcSEcCtD
Reboxetine—Diarrhoea—Irinotecan—colon cancer	0.000352	0.00198	CcSEcCtD
Reboxetine—Dry mouth—Capecitabine—colon cancer	0.000351	0.00197	CcSEcCtD
Reboxetine—Dizziness—Vincristine—colon cancer	0.000349	0.00196	CcSEcCtD
Reboxetine—Visual impairment—Methotrexate—colon cancer	0.000348	0.00195	CcSEcCtD
Reboxetine—Confusional state—Capecitabine—colon cancer	0.000347	0.00195	CcSEcCtD
Reboxetine—Infection—Capecitabine—colon cancer	0.000342	0.00192	CcSEcCtD
Reboxetine—Dizziness—Irinotecan—colon cancer	0.00034	0.00191	CcSEcCtD
Reboxetine—Shock—Capecitabine—colon cancer	0.000339	0.0019	CcSEcCtD
Reboxetine—Nervous system disorder—Capecitabine—colon cancer	0.000338	0.0019	CcSEcCtD
Reboxetine—Eye disorder—Methotrexate—colon cancer	0.000337	0.00189	CcSEcCtD
Reboxetine—Diarrhoea—Fluorouracil—colon cancer	0.000337	0.00189	CcSEcCtD
Reboxetine—Tinnitus—Methotrexate—colon cancer	0.000336	0.00189	CcSEcCtD
Reboxetine—Tachycardia—Capecitabine—colon cancer	0.000336	0.00189	CcSEcCtD
Reboxetine—Vomiting—Vincristine—colon cancer	0.000336	0.00189	CcSEcCtD
Reboxetine—Cardiac disorder—Methotrexate—colon cancer	0.000335	0.00188	CcSEcCtD
Reboxetine—Skin disorder—Capecitabine—colon cancer	0.000335	0.00188	CcSEcCtD
Reboxetine—Rash—Vincristine—colon cancer	0.000333	0.00187	CcSEcCtD
Reboxetine—Hyperhidrosis—Capecitabine—colon cancer	0.000333	0.00187	CcSEcCtD
Reboxetine—Dermatitis—Vincristine—colon cancer	0.000333	0.00187	CcSEcCtD
Reboxetine—Headache—Vincristine—colon cancer	0.000331	0.00186	CcSEcCtD
Reboxetine—Anorexia—Capecitabine—colon cancer	0.000328	0.00184	CcSEcCtD
Reboxetine—Angiopathy—Methotrexate—colon cancer	0.000327	0.00184	CcSEcCtD
Reboxetine—Vomiting—Irinotecan—colon cancer	0.000327	0.00184	CcSEcCtD
Reboxetine—Immune system disorder—Methotrexate—colon cancer	0.000326	0.00183	CcSEcCtD
Reboxetine—Dizziness—Fluorouracil—colon cancer	0.000326	0.00183	CcSEcCtD
Reboxetine—Mediastinal disorder—Methotrexate—colon cancer	0.000325	0.00183	CcSEcCtD
Reboxetine—Rash—Irinotecan—colon cancer	0.000324	0.00182	CcSEcCtD
Reboxetine—Dermatitis—Irinotecan—colon cancer	0.000324	0.00182	CcSEcCtD
Reboxetine—Chills—Methotrexate—colon cancer	0.000324	0.00182	CcSEcCtD
Reboxetine—Headache—Irinotecan—colon cancer	0.000322	0.00181	CcSEcCtD
Reboxetine—Hypotension—Capecitabine—colon cancer	0.000322	0.00181	CcSEcCtD
Reboxetine—Mental disorder—Methotrexate—colon cancer	0.000316	0.00177	CcSEcCtD
Reboxetine—Malnutrition—Methotrexate—colon cancer	0.000314	0.00176	CcSEcCtD
Reboxetine—Nausea—Vincristine—colon cancer	0.000314	0.00176	CcSEcCtD
Reboxetine—Vomiting—Fluorouracil—colon cancer	0.000313	0.00176	CcSEcCtD
Reboxetine—Insomnia—Capecitabine—colon cancer	0.000311	0.00175	CcSEcCtD
Reboxetine—Rash—Fluorouracil—colon cancer	0.000311	0.00174	CcSEcCtD
Reboxetine—Dermatitis—Fluorouracil—colon cancer	0.00031	0.00174	CcSEcCtD
Reboxetine—Paraesthesia—Capecitabine—colon cancer	0.000309	0.00174	CcSEcCtD
Reboxetine—Headache—Fluorouracil—colon cancer	0.000309	0.00173	CcSEcCtD
Reboxetine—Dysgeusia—Methotrexate—colon cancer	0.000308	0.00173	CcSEcCtD
Reboxetine—Dyspnoea—Capecitabine—colon cancer	0.000307	0.00172	CcSEcCtD
Reboxetine—Nausea—Irinotecan—colon cancer	0.000306	0.00172	CcSEcCtD
Reboxetine—Dyspepsia—Capecitabine—colon cancer	0.000303	0.0017	CcSEcCtD
Reboxetine—Decreased appetite—Capecitabine—colon cancer	0.000299	0.00168	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000297	0.00167	CcSEcCtD
Reboxetine—Constipation—Capecitabine—colon cancer	0.000294	0.00165	CcSEcCtD
Reboxetine—Nausea—Fluorouracil—colon cancer	0.000293	0.00164	CcSEcCtD
Reboxetine—Ill-defined disorder—Methotrexate—colon cancer	0.000291	0.00164	CcSEcCtD
Reboxetine—Anaemia—Methotrexate—colon cancer	0.00029	0.00163	CcSEcCtD
Reboxetine—Feeling abnormal—Capecitabine—colon cancer	0.000284	0.00159	CcSEcCtD
Reboxetine—Malaise—Methotrexate—colon cancer	0.000283	0.00159	CcSEcCtD
Reboxetine—Vertigo—Methotrexate—colon cancer	0.000282	0.00158	CcSEcCtD
Reboxetine—Gastrointestinal pain—Capecitabine—colon cancer	0.000282	0.00158	CcSEcCtD
Reboxetine—Leukopenia—Methotrexate—colon cancer	0.000281	0.00158	CcSEcCtD
Reboxetine—Urticaria—Capecitabine—colon cancer	0.000274	0.00154	CcSEcCtD
Reboxetine—Abdominal pain—Capecitabine—colon cancer	0.000272	0.00153	CcSEcCtD
Reboxetine—Body temperature increased—Capecitabine—colon cancer	0.000272	0.00153	CcSEcCtD
Reboxetine—Chest pain—Methotrexate—colon cancer	0.000267	0.0015	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000266	0.00149	CcSEcCtD
Reboxetine—Discomfort—Methotrexate—colon cancer	0.000264	0.00148	CcSEcCtD
Reboxetine—Confusional state—Methotrexate—colon cancer	0.000258	0.00145	CcSEcCtD
Reboxetine—Infection—Methotrexate—colon cancer	0.000255	0.00143	CcSEcCtD
Reboxetine—Hypersensitivity—Capecitabine—colon cancer	0.000254	0.00142	CcSEcCtD
Reboxetine—Nervous system disorder—Methotrexate—colon cancer	0.000251	0.00141	CcSEcCtD
Reboxetine—Skin disorder—Methotrexate—colon cancer	0.000249	0.0014	CcSEcCtD
Reboxetine—Hyperhidrosis—Methotrexate—colon cancer	0.000248	0.00139	CcSEcCtD
Reboxetine—Asthenia—Capecitabine—colon cancer	0.000247	0.00139	CcSEcCtD
Reboxetine—Anorexia—Methotrexate—colon cancer	0.000244	0.00137	CcSEcCtD
Reboxetine—Hypotension—Methotrexate—colon cancer	0.00024	0.00134	CcSEcCtD
Reboxetine—Diarrhoea—Capecitabine—colon cancer	0.000236	0.00132	CcSEcCtD
Reboxetine—Insomnia—Methotrexate—colon cancer	0.000232	0.0013	CcSEcCtD
Reboxetine—Paraesthesia—Methotrexate—colon cancer	0.00023	0.00129	CcSEcCtD
Reboxetine—Dyspnoea—Methotrexate—colon cancer	0.000229	0.00128	CcSEcCtD
Reboxetine—Somnolence—Methotrexate—colon cancer	0.000228	0.00128	CcSEcCtD
Reboxetine—Dizziness—Capecitabine—colon cancer	0.000228	0.00128	CcSEcCtD
Reboxetine—Dyspepsia—Methotrexate—colon cancer	0.000226	0.00127	CcSEcCtD
Reboxetine—Decreased appetite—Methotrexate—colon cancer	0.000223	0.00125	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Methotrexate—colon cancer	0.000221	0.00124	CcSEcCtD
Reboxetine—Vomiting—Capecitabine—colon cancer	0.000219	0.00123	CcSEcCtD
Reboxetine—Rash—Capecitabine—colon cancer	0.000217	0.00122	CcSEcCtD
Reboxetine—Dermatitis—Capecitabine—colon cancer	0.000217	0.00122	CcSEcCtD
Reboxetine—Headache—Capecitabine—colon cancer	0.000216	0.00121	CcSEcCtD
Reboxetine—Feeling abnormal—Methotrexate—colon cancer	0.000211	0.00119	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methotrexate—colon cancer	0.00021	0.00118	CcSEcCtD
Reboxetine—Nausea—Capecitabine—colon cancer	0.000205	0.00115	CcSEcCtD
Reboxetine—Urticaria—Methotrexate—colon cancer	0.000204	0.00114	CcSEcCtD
Reboxetine—Abdominal pain—Methotrexate—colon cancer	0.000203	0.00114	CcSEcCtD
Reboxetine—Body temperature increased—Methotrexate—colon cancer	0.000203	0.00114	CcSEcCtD
Reboxetine—Hypersensitivity—Methotrexate—colon cancer	0.000189	0.00106	CcSEcCtD
Reboxetine—Asthenia—Methotrexate—colon cancer	0.000184	0.00103	CcSEcCtD
Reboxetine—Diarrhoea—Methotrexate—colon cancer	0.000175	0.000985	CcSEcCtD
Reboxetine—Dizziness—Methotrexate—colon cancer	0.00017	0.000952	CcSEcCtD
Reboxetine—Vomiting—Methotrexate—colon cancer	0.000163	0.000915	CcSEcCtD
Reboxetine—Rash—Methotrexate—colon cancer	0.000162	0.000907	CcSEcCtD
Reboxetine—Dermatitis—Methotrexate—colon cancer	0.000161	0.000906	CcSEcCtD
Reboxetine—Headache—Methotrexate—colon cancer	0.000161	0.000901	CcSEcCtD
Reboxetine—Nausea—Methotrexate—colon cancer	0.000152	0.000855	CcSEcCtD
